Heart Failure and Acute Coronary Syndromes (ACS) Flashcards

1
Q

What is the definition of heart failure?

A

‘a complex syndrome that can occur from any structural or functional cardiac disorder that impairs the ability of the heart to fill with and eject blood and therefore to function efficiently as a pump to support a physiological circulation’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the main types of heart failure?

A

Heart failure due to reduced ejection fraction
- often called Left Ventricular Systolic Dysfunction or Systolic Heart Failure.

  • Heart failure with preserved ejection fraction
  • often called Diastolic heart failure.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the main signs and symptoms of Heart Failure?

A

SYMPTOMS

  • Fatigue
  • Breathlessness
  • Decreased exercise tolerance
  • Paroxysmal Nocturnal Dyspnoea

CLINICAL SIGNS

  • Fluid retention (oedema)
  • Raised venous pressure (elevated JVP) – usually raised by about 3cm
  • Abnormal heart sounds (S3 gallop rhythm)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NYHA Classification of Heart Failure

A

Class 1 - no limitations on physical activity

Class 2 - slight limitation, comfort at rest but ordinary physical activity causes symptoms

Class 3 - marked limitation of activity, comfort at rest but less than ordinary activity causes symptoms

Class 4 - unable to carry out any physical activity without discomfort, symptoms at rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Aetiology of Heart Failure

A

Is not a disease by itself but a consequence of some other disease process

Inability of myocytes to contract normally causes reduced cardiac output

Neuro-hormonal feedback further stresses already struggling cardiovascular system

In the developed world the most common cause is CORONARY ARTERY DISEASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is Heart Failure diagnosed?

A
  • History, Clinical signs
  • ECG
  • Chest X-ray
  • Lab tests – troponin, U&E
  • Natriuretic peptides
  • Echocardiography
  • Cardiac angiography
  • Cardiac MRI

ECHO diagnosis of heart failure
- Reduced ejection fraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the treatment aims in Heart Failure?

A
  • Reduce symptoms
  • Improve quality of life
  • Improve life expectancy
  • Reduce hospital admissions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the main non-pharmacological treatments for heart failure?

A
  • Exercise
  • Diet
  • Weight reduction
  • Reduce alcohol consumption
  • Stop smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the main pharmacological treatments for heart failure to improve mortality/morbidity?

A

First-line

  • ACEi / ARBs
  • Beta blockers
  • Aldosterone antagonists

Additional therapy

  • Hydralazine and Nitrate combination
  • Ivabradine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the main pharmacological treatments for heart failure to improve symptoms?

A
  • Diuretics
  • ACEi / ARBs
  • Beta blockers
  • Aldosterone antagonists
  • Hydralazine and Nitrate combination
  • Digoxin
  • Ivabradine (slows the heart rate down and is useful for when you can’t increase other meds due to risk of low BP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What monitoring is normally necessary in patients with heart failure?

A

Patient education

Carer support

Monitor fluid balance and U&Es
- Recommend that paitnets weigh themselves often to monitor fluid gain. ‘dry weight’ = weight on discharge. If increased fluids -> increase diuretic

End of life discussion

Role of Heart Failure Nurse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the initial symptoms of acute coronary syndrome?

A
  • Chest pain
  • Raised cardiac markers (e.g. troponin)
  • ECG changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the cardiac markers that will be raised in acute coronary syndrome?

A

Cardiac troponins (Tnt and TnI)

  • Sensitive and specific for myocardial damage
  • Levels taken on arrival, at 6 hours and at 12 hours.
  • Levels peak within 12 hours and fall slowly for up to 2 weeks
  • Damage to cardiac muscle of any kind will cause increased markers

Creatinine Kinase (CK, CK-MB)

  • Rises 6 hours post infarction and falls after around 36 hours
  • Not selective for myocardial damage as also found in skeletal muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the comparisons between unstable angina (UA), NSTEMI and STEMI?

A

Unstable Angina (UA)

  • Chest pain
  • Troponin negative
  • Normal/unchanged ECG

NSTEMI

  • Chest pain
  • Troponin positive
  • ST segment depression and/or T wave inversion

STEMI

  • Chest pain
  • Troponin positive
  • ST segment elevation greater than 1mm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What treatment is normally used for STEMI?

A

Thrombolytics and PCI (Percutaneous Coronary Intervention)

Ideally within 1 hour of the onset of symptoms

+ Drugs for secondary prevention of CHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What treatment is normally used for NSTEMI?

A

Glycoprotein 2B/3A inhibitors

+ Drugs for secondary prevention of CHD

17
Q

What drugs are normally used for the secondary prevention of CHD?

A

Antiplatelet therapy (typically low dose aspirin)

Statin

ACEi

B-blocker

In addition the following may also be indicated

  • Clopidogrel/Ticagrelor/Prasugrel for up to 12 months (depending on diagnosis)
  • Aldosterone antagonist (Eplerenone or Spironolactone)
18
Q

Oral anti-platelet drugs for secondary prevention of CHD

A

Aspirin 75mg, usually lifelong.

Second antiplatelet drug in combination with aspirin for 12 months following NSTEMI and after PCI.

  • Options are Clopidogrel, Ticagrelor or Prasugrel (STEMI only)
  • Ticagrelor and Prasugrel have more predictable effect. Greater risk reduction but greater bleed risk
19
Q

Statins for secondary prevention of CHD

A

Aggressive high dose treatment should be offered to patients presenting with ACS

  • Atorvastatin 80mg daily
  • Simvastatin 80mg nocte (risk of rhabdomyolysis)
  • Rosuvastatin 20mg daily (not licensed for this indication)
20
Q

B-blockers for secondary prevention of CHD

A

Beta-blockers confer prognostic benefit acutely and medium term following myocardial infarction. Also give symptomatic benefit from angina.

Stay on for at least 12 months
- may then be stopped if necessary as the evidence for effectiveness is not as good after this point. No real harm in carrying on.

21
Q

ACEi for secondary prevention of CHD

A

Clinically ACEi reduce arterial pressure and cardiac load
- however as they do not effect cardiac contractility, unlike other vasodilators, cardiac output is increased.

Particularly important in the presence of any left ventricular impairment whether symptomatic or not.

Monitor for cough
- switch to ARB if necessary

22
Q

Aldosterone antagonists for secondary prevention of CHD

A

Recommended by NICE for patient with evidence of heart failure post MI (ejection fraction